WF 7.5 G (Warfarin 7.5 mg)

Pill imprint WF 7.5 G has been identified as Warfarin sodium 7.5 mg.

Warfarin is used in the treatment of prevention of thromboembolism in atrial fibrillation; deep vein thrombosis, first event; antiphospholipid syndrome; deep vein thrombosis prophylaxis after hip replacement surgery; pulmonary embolism, recurrent event (and more), and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Warfarin 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Warfarin sodium

Imprint:

WF 7.5 G

Strength:

7.5 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Coumarins and indandiones

Pregnancy Category:

D - Positive evidence of risk - for women with mechanical heart valves
X - Not for use in pregnancy - for other pregnant populations

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-8875

Inactive Ingredients:

corn starch
lactose monohydrate
magnesium stearate
stearic acid
D&C Yellow No. 10
FD&C Yellow No. 6

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.